LEIDEN JEFFREY M sold VRTX
February 13, 2024 · Form 4 insider transaction
LEIDEN JEFFREY M sold 737 shares of Vertex Pharmaceuticals Incorporated at $419.13 per share, a transaction worth $308.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1, which was entered into on 08/04/2023.; Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.; Open market sales reported on this line occurred at a weighted average price of $419.13 (range $419.00 to $419.37).